HK Stock MarketDetailed Quotes

02186 LUYE PHARMA

Watchlist
  • 2.140
  • -0.020-0.93%
Market Closed Dec 20 16:08 CST
8.05BMarket Cap9.55P/E (TTM)

LUYE PHARMA Key Stats

LUYE PHARMA Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/H1-- / 3.191B--
--2024/H2-- / 3.433B--
Mar 27, 20242023/H23.239B / 3.182B--
Aug 29, 20232023/H12.904B / 2.976B--
Mar 29, 20232022/H23.131B / 2.993B--
DatePeriodRevenue/EstimateEarnings Call
--2025/H1-- / 3.191B--
--2024/H2-- / 3.433B--
Mar 27, 20242023/H23.239B / 3.182B--
Aug 29, 20232023/H12.904B / 2.976B--
Mar 29, 20232022/H23.131B / 2.993B--

Unlock Free Earnings Estimates

LUYE PHARMA Earnings Reports

Read more

Trending HK Stocks
HK Crypto ETF HK Crypto ETF

An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data. An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 22, 2024

Strong Buy

  • Strong Buy

    100.00%
  • Buy

    0.00%
  • Hold

    0.00%
  • Underperform

    0.00%
  • Sell

    0.00%

Price Target

No Data